pexacerfont: Clinical Trials

1 trial of pexacerfont, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow pexacerfont: new trials by email Literature Review of pexacerfont trials Research Report on pexacerfont

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
pexacerfont, escitalopram, placebo - Generalized Anxiety Disorder
Phase 2 / Phase 3CompletedBristol-Myers Squibb2602007-07-012015-10-12

Conditions studied

Generalized Anxiety Disorder (1)

Sponsors

Bristol-Myers Squibb (1)

Countries

United States (1)

Results publications

PMID 20455246